The traditional diagnostic strategy for cancer of the prostate, based on a threshold Prostatic Specific Antigen (PSA) value along with performing systematic transrectal ultrasound-guided biopsy (12 biopsies sampling the 17 mm of the posterior part of the gland), is associated with diagnostic errors
